|
|
||||||||
Ann Thorac Surg 2007;84:314-316
© 2007 The Society of Thoracic Surgeons
Division of Cardiac Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
Accepted for publication September 19, 2006.
* Address correspondence to Dr Toyoda, Division of Cardiac Surgery, University of Pittsburgh Medical Center, 200 Lothrop St, C-700 PUH, Pittsburgh, PA 15213 (Email: toyoday{at}upmc.edu).
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
| Technique |
|---|
|
|
|---|
-1 antitrypsin deficiency and progressive respiratory insufficiency. She had chronic rejection develop. She was evaluated for re-transplantation and was ultimately placed on the lung transplant waiting list for double-lung transplantation. Her height was 163 cm and her weight was 42 kg. A pulmonary function test in September 2004 showed a forced vital capacity (FVC) of 1.46 L (43% predicted), forced expiratory volume in 1 second (FEV1) of 0.43 L (16% predicted), and FEV1/FVC of 29%. A potential donor became available and she was taken to the operating room in March 2005. The donor was a 58-year-old woman who died of a stroke and was hospitalized for 3 days. The donors height was 173 cm and her weight was 69 kg. The donor had a history of hypertension, but no smoking history. The donor had undergone mitral valve replacement through a median sternotomy in 2002 for bacterial endocarditis. The donors medication included Coumadin (warfarin, Bristol-Myers Squibb, New York, NY) and metoprolol. A chest roentgenogram showed clear lungs, and a bronchoscopy showed a clear bronchial tree. Blood gas on PIO
2 of 1.0 and positive end-expiratory pressure of 5 cm H2O showed PaO
2 of 526 mm Hg and PCO
2 of 43 mm Hg. The donor lungs were harvested bilaterally through a redo median sternotomy without any injuries, using the technique described as follows. For the recipient, a clamshell incision and bilateral anterior thoracotomy through the fourth intercostal space extending across the midline were carried out. The adhesions due to prior single-lung transplant were quite dense and therefore were dissected out entirely. Double lung re-transplantation was performed in a usual fashion in which an end-to-end bronchial anastomosis was done with 3-0 Prolene [Ethicon, Somerville, NJ], an end-to-end pulmonary arterial anastomosis with 5-0 Prolene [Ethicon], and an end-to-end left atrial cuff with 4-0 Prolene [Ethicon] in a running fashion. For each side, 800 cc of cold pneumoplegia was given after the bronchial anastomosis, and 800 cc of warm pneumoplegia was given before reperfusion. The ischemic time of the left lung was 253 minutes and the right lung was 401 minutes. For immunosuppression, the patient received 30 mg of Campath (alemtuzumab, Berlex Laboratories, Wayne, NJ) as an induction at the start of the operation, 250 mg of Solu-Medrol (methylprednisolone, Pfizer, New York, NY) was given before reperfusion for each side, and tacrolimus-based maintenance therapy was used. The patient was extubated postoperatively on day 2, transferred to the floor on postoperative day 4, and discharged home on postoperative day 24 with oxygen saturation of 98% on room air. There were no significant air leaks postoperatively, and the four chest tubes (two in each chest) were removed by postoperative day 8. Her biopsy showed minimal acute cellular rejection and no evidence of obliterans bronchiolitis. She is doing well 1 year postoperatively, with FVC of 2.06 L (61% predicted), FEV1 of 1.95 L (75% predicted), and FEV1/FVC of 95%.
Patient 2
The patient was a 38-year-old woman who had undergone double-lung transplantation in August 2002 for pulmonary fibrosis and progressive respiratory insufficiency. She had chronic allograft dysfunction with bronchiolitis obliterans syndrome develop, and she was ultimately listed for a double-lung re-transplantation. Her height was 170 cm and her weight was 61 kg. A pulmonary function test in November 2004 showed a FVC of 1.64 L (44% predicted), FEV1 of 0.48 L (17% predicted), and FEV1/FVC of 29%. A potential donor became available and she was taken to the operating room in April 2005. The donor was a 54-year-old man who died of stroke and was hospitalized for 3 days. The donors height was 177 cm and his weight was 68 kg. The donor had a history of hypertension, hyperlipidemia, cerebrovascular accident with seizure, and end-stage renal dysfunction with hemodialysis since 2000; he had no smoking history. The donor had undergone mitral valve replacement through a median sternotomy in May 2004. The donors medication included aspirin, Plavix (clopidogrel, Apotex, Ontario, Canada), and Lipitor (atorvastatin, Pfizer, New York, NY). A chest roentgenogram showed atelectasis in the left base, otherwise clear lungs, and a bronchoscopy showed a clear bronchial tree. Blood gas on PIO2 of 1.0 and positive end-expiratory pressure of 5 cm H2O showed PaO
2 of 510 mm Hg and PCO
2 of 44 mm Hg. The donor lungs were harvested bilaterally without any injuries. The recipient received a clamshell incision and a bilateral anterior thoracotomy through the fourth intercostal space extending across the midline. The adhesions due to prior double-lung transplant were extremely dense and were dissected out entirely. Double-lung re-transplantation was performed in a way described in the first case, except for the bronchial anastomosis in which an end-to-end bronchial anastomosis was performed in an intussusceptive fashion using 3-0 Prolene running suture [Ethicon] for the membranous portion and 3-0 polydioxanone interrupted mattress suture for the rest, due to the size mismatch. The ischemic time of the right lung was 333 minutes and the left was 463 minutes. The patient was extubated postoperatively on day 1, transferred to the floor on postoperative day 3, and discharged home on postoperative day 15 with an oxygen saturation of 99% on room air. There were no significant air leaks postoperatively, but the four chest tubes (two in each chest) were removed by postoperative day 10 because of persistent pleural effusion, most likely due to adhesions in the redo double-lung transplantation. Biopsy showed no acute cellular rejection and no evidence of obliterans bronchiolitis. She is doing well 11 months postoperatively, with a FVC of 2.60 L (70% predicted), FEV1 of 2.23 L (77% predicted), and FEV1/FVC of 86%.
Donor Harvest Technique
The importance of the technique for donor harvesting is to avoid unnecessary dissection (especially behind the sternum, which can potentially cause injury to the lung, heart, or both) and to harvest quickly as other teams also harvest abdominal organs. The technique is described as follows, supposing that a single surgeon is harvesting the lungs with no assistants.
Median sternotomy: (1) usual skin incision followed by removing the previous wires; (2) sternotomy with oscillating saw: first the anterior plate and then the posterior plate with the lungs down; (3) dissect behind the sternum minimally enough to place a chest spreader; (4) putting a small retractor such as an Army-Navy in between the split sternum helps to keep the minimum space to access to the back of the sternum for dissection without tearing the right ventricle or the innominate vein.
| Comment |
|---|
|
|
|---|
The heart will be dissected after the decision is made to utilize the lungs. At least the pulmonary artery must be exposed for pneumoplegia, the left atrial appendage for left-sided drainage and the inferior vena cava for right-sided drainage before cross clamping. Eventually, the pulmonary artery needs to be free from the aorta and SVC, and the pulmonary veins and left atrium need to be freed for adequate cuff. It is easier to dissect the front, right, and inferior aspect of the heart before cross clamping, and the left lateral and posterior aspects after cross clamping. All the remaining adhesions, mainly on the left to the posterior surface of the heart can be cleared quickly with blunt and sharp dissection after cross clamping.
Both donors in this report had undergone mitral surgery and had mild to moderate adhesions in the pleural spaces. As long as the surgeons dissect the lungs away from the lungs and close to the parietal pleura or the chest wall (we do not have to preserve phrenic nerves), the lungs should be able to be harvested without any injuries. Therefore, we believe we should be able to harvest lungs safely from a donor with previous coronary artery bypass grafting in which there may be more adhesions related to the left internal mammary artery harvest. To access to the inferior pulmonary ligament, the heart should be retracted toward the opposite side and placed in the contralateral chest cavity, and the pericardium should be cut transversely down to the inferior vena cava. The adhesions posterior to the hilum should be dissected after cross clamping to avoid too much stress to the heart and lungs.
This report shows that lungs from a donor with prior cardiac surgery can be successfully used for lung transplantation. The number of available donor lungs will be increased by this strategy described in this article.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Zuin, G. Marulli, M. Loy, and F. Rea Clamshell approach for lung harvest in donor with previous aortic valve substitution Eur. J. Cardiothorac. Surg., January 1, 2009; 35(1): 181 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Toyoda, J. Thacker, R. Santos, D. Nguyen, J. Bhama, C. Bermudez, R. Kormos, B. Johnson, M. Crespo, J. Pilewski, et al. Long-Term Outcome of Lung and Heart-Lung Transplantation for Idiopathic Pulmonary Arterial Hypertension Ann. Thorac. Surg., October 1, 2008; 86(4): 1116 - 1122. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |